Instrument Business Outlook Volume 30 - Issue 11

15 Sep 2021

Categories:

Instrument Business Outlook

Table of Contents

Avantor, Bio-Techne and MilliporeSigma Share Their Latest Mid-Term Financial Outlooks
- Avantor: Production Workflows a Priority
- Bio-Techne: More M&A on the Radar
- Merck KGaA: Guidance Raised
Changing Industry Drives Semiconductor Demand for Instrumentation
Executive Briefing
- Avantor Announces $2.9 Billion Acquisition to Expand Single-Use Business
- Oxford Nanopore Files for IPO
- Lab Equipment Supplier to Go Public in Japan
- Maravai Divests Protein Detection Business
- SomaLogic Completes IPO
- Flow Cytometry Software Company Acquired
- Agena Biosciences Finds New Owner
Second Quarter Results: Bio-Techne, Biotage, Pacific Biosciences, Shimadzu and Tecan
- Bio-Techne’s Fiscal 2021 Sales Encourage an Optimistic Forecast for Fiscal 2022
  - Q4 and FYE
- Biotage Sees Sales Recovery in the Americas
- Pacific Biosciences Observes Broad-Based Gains Geographically
- Shimadzu Posts a Triple-Digit Sales Increase in South America
- Tecan Predicts Sustained Revenue Contributions from the COVID-19 Marketplace
Market Profile: FTIR Wine Analyzers
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Clinical
- Pharmaceutical
- Chemicals
Region Watch
- China
- Germany
- UK
News
- Broad-Based Companies
  - Company Announcements
  - Product Introductions
- MS & LC/MS
  - Company Announcements
  - Product Introductions
- Surface Science
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Life Science Consumables
  - Company Announcements
  - Gene-Based Analysis
  - Company Announcements
  - Product Introductions
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Protein-Based Analysis
  - Company Announcements
  - Product Introductions
Bottom Line

Attachments

IBO 091521 Issue.pdf